|
Volumn 195, Issue 2, 2010, Pages 524-527
|
Evaluation of nonenhancing tumor fraction assessed by dynamic contrast-enhanced MRI subtraction as a predictor of decrease in tumor volume in response to chemoradiotherapy in advanced cervical cancer
|
Author keywords
Cervical cancer; Dynamic contrast enhanced MRI; Nonenhancing fraction; Perfusion; Predictor; Subtraction
|
Indexed keywords
CISPLATIN;
GADOLINIUM PENTETATE;
CONTRAST MEDIUM;
ADULT;
ADVANCED CANCER;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER SIZE;
CLINICAL ARTICLE;
EXTERNAL BEAM RADIOTHERAPY;
FEMALE;
HUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
NUCLEAR MAGNETIC RESONANCE SCANNER;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
TREATMENT RESPONSE;
UTERINE CERVIX CANCER;
UTERINE CERVIX CARCINOMA;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
DIAGNOSTIC USE;
IMAGE ENHANCEMENT;
IMAGE SUBTRACTION;
MIDDLE AGED;
PROCEDURES;
PROGNOSIS;
REPRODUCIBILITY;
SENSITIVITY AND SPECIFICITY;
TREATMENT OUTCOME;
UTERINE CERVICAL NEOPLASMS;
YOUNG ADULT;
ADULT;
CHEMOTHERAPY, ADJUVANT;
CONTRAST MEDIA;
FEMALE;
GADOLINIUM DTPA;
HUMANS;
IMAGE ENHANCEMENT;
MAGNETIC RESONANCE IMAGING;
MIDDLE AGED;
PROGNOSIS;
RADIOTHERAPY, ADJUVANT;
REPRODUCIBILITY OF RESULTS;
SENSITIVITY AND SPECIFICITY;
SUBTRACTION TECHNIQUE;
TREATMENT OUTCOME;
UTERINE CERVICAL NEOPLASMS;
YOUNG ADULT;
|
EID: 77955632238
PISSN: 0361803X
EISSN: 15463141
Source Type: Journal
DOI: 10.2214/AJR.09.3437 Document Type: Article |
Times cited : (32)
|
References (8)
|